The Boards of Directors of both companies have unanimously approved the transaction. Anacors flagship asset, crisaborole, a differentiated non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, is currently under review by the U.S. FDA for ... India Infoline, 1 week ago
US Treasury tax reforms force Pfizer to rethink mega merger - International Bar Association, 5 days ago
Pfizer buying Anacor for $5.2 bln. - Financial Express, 1 week ago
3 images for "Director From Pfizer"
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 06, 2016, inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 01, 2016 to March 31, 2016 and ...Money Control, 4 weeks ago Pfizer recommends 150% dividend Money Control, 2 weeks ago S Sridhar becomes Pfizer India MD Times of India, 2 months ago Pfizer appoints S.Sridhar as MD The Hindu, 2 months ago
PRESS RELEASE Pfizer Inc. (NYSE:PFE) and Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total ...Pharmacy Times, 6 days ago Anacor Pharmaceuticals Stock Rockets Following News Of Pfizer Purchase Investing.com, 1 week ago
Pfizer has moved to stop its drugs being used for executions by imposing strict distribution controls that will stop them reaching execution chambers across the US. This means that all US Food and Drug Administration (FDA) approved manufacturers of ...RSC, 16 hours ago The End of the Open Market for Lethal-Injection Drugs New Yorker, 3 days ago Drug company's withdrawal limits death penalty options in Alabama Pharmacist.com, 4 days ago PFIZER : Blocks Use of Its Drugs in U.S. Executions 4 Traders, 5 days ago
Piramal Enterprises is acquiring four brands of US drug maker Pfizer for Rs 110 crore, the third such acquisition by the Mumbai-based company in the past six months, in line with the strategy to expand its consumer product business. The company, ...Pharmaceutical Tech.com, 1 week ago Piramal Enterprises to buy 4 Pfizer brands for Rs 110 cr HT Syndication, 1 week ago Piramal to buy 4 brands from Pfizer for Rs 110 cr Deccan Herald, 1 week ago
The four brands being acquired include child nutrition supplement Ferradol, medicated soap Neko, pain reliver Sloan and cough syrup Waterbury's compound, which have a combined market size of an estimated at Rs7,000 crore. "The company's consumer ...Equilibrio Informativo, 1 week ago Piramal Enterprises buys four Pfizer brands for Rs110 crore India Brand Equity Foundation, 1 week ago Piramal Enterprises up 2%, to acquire 4 brands from Pfizer Moneycontrol.com, 1 week ago Piramal to acquire 4 brands of Pfizer The Financial Chronicle, 1 week ago
Details Category: More News Published on Monday, 16 May 2016 18:32 Hits: 78 Strong fit with Pfizer's Inflammation and Immunology portfolio Expected to enhance near-term revenue growth for the innovative business Anacor's flagship asset, ...PipelineReview, 1 week ago PFIZER : to Acquire Anacor 4 Traders, 1 week ago
A federal appeals court last week refused to revive a lawsuit in which a former Pfizer employee alleged the company promoted off-label use of its Lipitor cholesterol pill. In doing so, however, the court also raised a question about the extent to ...StatNews.com, 11 hours ago Lawsuit Claims RAPP CEO Told Employees, I Will Break Off Your Finger and Shove It Up Your Ass. Adweek Online, 6 days ago Rapp rocked as fired exec slams destructive Orlov DecisionMarketing, 5 days ago Lawsuit claims ad agency CEO 'pressured' female employee to get him free Viagra Business Insider Australia, 6 days ago
Pfizer (NYSE:PFE) has announced that it will acquire Palo Alto-based biopharmaceutical company Anacor Pharmaceuticals (ANAC) for approximately $5.2 billion in a deal which is expected to strengthen Pfizer's inflammation and immunology portfolio. ...Equilibrio Informativo, 3 days ago Pfizer to buy California-based biopharma company, Anacor for $5.2 billion PharmaBiz, 1 week ago Pharmaceuticals M&A: Pfizer Inc. to Buy Anacor Pharmaceuticals Inc for $4.5 Billion InvestorPlace.com, 1 week ago Valeant Pharmaceuticals Intl Inc (VRX): Should Investors Expect an Upside? Bidness Etc, 5 days ago
By Jon Herskovitz and Fiona Ortiz May 17 (Reuters) - More than 20 U.S. states that use a combination of drugs to carry out lethal injections will find it harder to conduct executions due to Pfizer's ban on sales of its chemicals, but the move will ...Yahoo! Finance, 1 week ago USA: Reprieve states Pfizer's policy opposing lethal injections is exemplary & warns against passing secrecy laws Business & Human Rights, 1 week ago Pfizer Ban: The Ban On Lethal Drug Sales Has Complicated Executions For At Least 20 States In The U.S. Inquisitr, 6 days ago Pfizer ban on lethal drug sales... DailyNews724.com, 6 days ago
on your WebpageAdd Widget >Get your members hooked!